Oral Antibiotics Market, By Dosage Form (Tablet, Capsule, Oral suspension, Oral solution/ready-to-drink, and Granules/sachets), By Drug Class (Penicillins (Amoxicillin, Ampicillin, Others), Cephalosporins (Cephalexin, Cefpodoxime, Others), Macrolides (Azithromycin, Clarithromycin, Others), Lincosamides (Clindamycin), Tetracyclines (Doxycycline, Minocycline, Others), Fluoroquinolones (Ciprofloxacin, Levofloxacin, Others), Oxazolidinones (Linezolid, Tedizolid, Others), Sulfonamide (trimethoprim–sulfamethoxazole), Nitroimidazoles (Metronidazole, Tinidazole, Others), and Others (Rifamycins, Nitrofurans, Glycopeptides, Macrocyclics, etc.)), By Application (Respiratory tract infections, Skin and soft tissue infections, Urinary tract infections, Gastrointestinal/enteric infections, Sexually transmitted infections, Dental/orofacial infections, Clostridioides difficile infection, and Others (Mycobacterial infections)), By Release Profile (Immediate-release and Extended-release/delayed-release), By Spectrum of Activity (Broad-spectrum antibiotics and Narrow-spectrum antibiotics), By Patient Group (Adult, Pediatric, and Geriatric), By Prescription Type (Prescription Drugs and Over-the-Counter (OTC)), By Manufacturer Type (Branded and Generics), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)